Paxman AB Stock
Stocks
PAX
SE0009806284
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Nasdaq Stockholm
20:00:00 19/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 68.50 SEK | +3.16% |
|
+9.60% | +21.89% |
| 11-13 | Paxman's neuropathy product advances in FDA review process | FW |
| 11-04 | Paxman launches new system to prevent nerve damage during chemotherapy | FW |
| Market Cap | 1.59B 156M 142M 132M 119M 224M 14.6B 234M 632M 7.89B 587M 574M 25B | P/E 2026 * |
56.1x | P/E 2027 * | 16.3x |
|---|---|---|---|---|---|
| Enterprise Value | 1.46B 144M 131M 121M 109M 205M 13.4B 215M 580M 7.24B 538M 527M 22.95B | EV / Sales 2026 * |
3.53x | EV / Sales 2027 * | 2.68x |
| Free-Float |
64.49% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| PAX | Delayed | |
| B0F | Delayed |
Last Transcript: Paxman AB
| 1 day | +3.16% | ||
| 1 week | +9.60% | ||
| Current month | +3.32% | ||
| 1 month | +8.21% | ||
| 3 months | +57.29% | ||
| 6 months | +37.00% | ||
| Current year | +21.89% |
| 1 week | 62.5 | 68.9 | |
| 1 month | 61.1 | 69.9 | |
| Current year | 41 | 69.9 | |
| 1 year | 41 | 69.9 | |
| 3 years | 28.6 | 85.8 | |
| 5 years | 22 | 85.8 | |
| 10 years | 9.55 | 85.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Paxman
CEO | Chief Executive Officer | 43 | 20/12/2016 |
Emma Thornhill
DFI | Director of Finance/CFO | 41 | 01/01/2017 |
| Director of Finance/CFO | 46 | 01/03/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Paxman
BRD | Director/Board Member | 43 | 10/02/2017 |
| Chairman | 72 | 01/12/2016 | |
Glenn Paxman
BRD | Director/Board Member | 70 | 20/12/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/26/26 A | Buy | Chairman | 2,500 | 0.0107% | ||
| 5/26/26 A | Buy | Chairman | 1,000 | 0.0043% | ||
| 5/25/26 A | Sell | Chief Executive Officer | -60,000 | 0.2578% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.16% | +9.60% | +10.48% | +129.87% | 152M | ||
| -0.58% | -4.96% | -20.10% | +4.34% | 181B | ||
| -0.11% | -0.98% | -0.19% | +34.58% | 123B | ||
| -1.59% | -1.79% | -12.92% | +8.57% | 121B | ||
| -2.21% | -3.15% | -43.22% | -1.44% | 91.11B | ||
| -2.03% | -2.47% | -5.64% | +75.00% | 66.47B | ||
| -1.57% | -0.86% | +10.58% | -8.83% | 58.86B | ||
| -1.26% | -1.84% | +2.90% | +48.73% | 55.03B | ||
| -1.68% | -3.78% | +1.67% | +39.81% | 48.88B | ||
| +1.60% | +6.46% | +5.64% | +1.34% | 35.5B | ||
| Average | -0.62% | +0.29% | -5.08% | +33.20% | 78B | |
| Weighted average by Cap. | -1.07% | -1.21% | -10.84% | +19.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 414M 40.66M 37.04M 34.29M 31.02M 58.19M 3.8B 60.9M 164M 2.05B 153M 149M 6.5B | 516M 50.61M 46.11M 42.69M 38.61M 72.44M 4.73B 75.81M 205M 2.55B 190M 186M 8.09B |
| Net income | 29M 2.84M 2.59M 2.4M 2.17M 4.07M 266M 4.26M 11.5M 144M 10.67M 10.45M 455M | 99M 9.71M 8.85M 8.19M 7.41M 13.9M 907M 14.55M 39.27M 490M 36.43M 35.67M 1.55B |
| Net Debt | -131M -12.85M -11.71M -10.84M -9.8M -18.39M -1.2B -19.25M -51.96M -648M -48.21M -47.2M -2.05B | -210M -20.6M -18.77M -17.37M -15.71M -29.48M -1.92B -30.85M -83.3M -1.04B -77.28M -75.66M -3.29B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/11/26 | SEK 68.50 | +3.16% | 84,705 |
| 18/11/26 | SEK 66.40 | -0.60% | 27,931 |
| 17/11/26 | SEK 66.80 | +1.21% | 3,174 |
| 16/11/26 | SEK 66.00 | -2.22% | 14,943 |
| 13/11/26 | SEK 67.50 | +8.00% | 53,268 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- PAX Stock
Select your edition
All financial news and data tailored to specific country editions
















